Acceptability, tolerability and safety of the BRIGhTMIND trial: Connectivity-guided intermittent theta-burst stimulation versus F3- repetitive transcranial magnetic stimulation for treatment-resistant depression

Acceptability, tolerability and safety of the BRIGhTMIND trial: Connectivity-guided intermittent theta-burst stimulation versus F3- repetitive transcranial magnetic stimulation for treatment-resistant depression

Background: The BRIGhTMIND study was a double-blind RCT comparing repetitive transcranial magnetic stimulation at a standard simulation site (the “F3” location given by the International 10–20 system, F3-rTMS) versus connectivity-guided intermittent theta burst stimulation (cgiTBS) for treatment-res...

Full description

Saved in:
Bibliographic Details
Main Authors: Lucy Webster, Clement Boutry, Louise Thomson, Mohamed Abdelghani, Shaun Barber, Paul M. Briley, Micheal Kurkar, Sudheer Lankappa, R. Hamish McAllister-Williams, Ana Suazo Di Paola, Richard Morriss
Format: Article
Language:English
Published: Elsevier 2025-01-01
Series:Comprehensive Psychiatry
Subjects:
Transcranial magnetic stimulation
Depression
Safety
Acceptability
Tolerability
Treatment-resistant depression
Online Access:http://www.sciencedirect.com/science/article/pii/S0010440X24000956
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items